Mundipharma A/S: Financial statements 2013
CVR: 17981994
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
Mundipharma A/S (CVR 17981994) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 2,097,309,000 and a net result of DKK 4,453,000. The profit margin was 0.2%. Equity in the 2013 report amounted to DKK 72,998,000. The solvency ratio was 7.3%. The company had 48 employees in the financial year.
- Revenue
- DKK 2,097,309,000
- Gross Profit
- DKK 41,480,000
- Profit/Loss
- DKK 4,453,000
- Equity
- DKK 72,998,000
- Total Assets
- DKK 998,384,000
- Employees
- 48
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of June 25, 2013, JUT NR. 2180 A/S has been appointed auditor of Mundipharma A/S.
As of June 25, 2013, JUT NR. 2180 A/S has stepped down as auditor of Mundipharma A/S.
Mundipharma A/S has published its annual report for 2012.
About Mundipharma A/S
Mundipharma A/S is a Danish company of the type Aktieselskab based in Vedbæk, founded in 1994. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Norpharma A/S and NORPHARMA A/S. The management consists of Lisbeth Kattenhøj. The board consists of Stephen Johan Jamieson (chair), Bryan George Lea and Lisbeth Kattenhøj. The company is owned by Halm S.à.r.l., RSS Captain Trust Holdings LLC and JDS Captain Trust Holdings LLC. The company has 3 employees (2026). In 2025, the company reported revenue of DKK 25,912,000 and a net result of DKK 672,000 compared with DKK 514,000 the year before. Equity in the 2025 report amounted to DKK 38,165,000.
